Skip to content

Clinical trials

Phase 3 Genetic Diseases, Inborn trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Genetic Diseases, Inborn Phase: Phase 3 Country / region: Netherlands Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20181
20191
20211
20221
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Avidity Biosciences, Inc.1
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company1
Grifols Therapeutics LLC1
Kyntra Bio1
NewAmsterdam Pharma1
Pfizer1
Pharming Technologies B.V.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Genetic Diseases, Inborn7
Muscular Diseases2
Muscular Disorders, Atrophic2
Muscular Dystrophies2
Muscular Dystrophy, Duchenne2
Musculoskeletal Diseases2
Nervous System Diseases2
Neuromuscular Diseases2
Angioedema1
Angioedemas, Hereditary1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.